Login
Menu
Home
(current)
Recurring Events
CE Calendar
Evaluations
Enduring Materials
Live Events
Exhibit
CE Applications
Links
Login
Annual Diagnostic Update In Pathology and Laboratory Medicine
Exhibitors
Bristol Myers Squibb Hematology
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
https://www.bms.com/
https://www.linkedin.com/company/bristol-myers-squibb/mycompany/verification/
Caris Life Sciences
Treating Cancer Smarter:
The Caris Molecular IntelligenceĀ® comprehensive tumor profiling approach to assess DNA, RNA and Proteins reveals the highest quality molecular blueprint to guide more precise and individualized treatment decisions that is proven to extend overall survival.
https://www.carismolecularintelligence.com/
https://www.facebook.com/login/?next=https%3A%2F%2Fwww.facebook.com%2FCarisLifeSciences%2F
https://www.linkedin.com/company/caris-life-sciences
https://twitter.com/carisls
Genentech
https://www.gene.com/
Karius
Karius is a life sciences company focused on saving lives. We advance diagnostic science and technology in order to deliver breakthroughs and upgrade the standard of care in the fight against infectious disease.
The Karius Test⢠is a liquid biopsy for infectious diseases that can free clinicians from the diagnostic maze so they can return patients back to health quickly and safely.
From a single blood sample, the Karius Test can non-invasively and rapidly detect over 1000 pathogens causing both deep-seated and bloodstream infections. The Karius Test helps clinicians avoid invasive, low-yield, and sequential diagnostic tests that can delay treatment for the most vulnerable hospitalized patients.
https://kariusdx.com/
https://www.facebook.com/kariustest/
https://www.linkedin.com/company/kariusinc/mycompany/
https://twitter.com/KariusInc?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Seagen
Powered By
eeds Privacy and Registration Refund Policy
|
eeds Accessibility Statement